(HealthDay)—Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of
Continue reading »Home »
Critically ill patients supported by respirators in ICUs may develop weakness from drug treatment, not illness
At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units (ICUs) develop muscular weakness
Continue reading »